These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29964149)

  • 41. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.
    Pene F; Claessens YE; Muller O; Viguié F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D
    Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro treatment of melanoma brain metastasis by simultaneously targeting the MAPK and PI3K signaling pathways.
    Daphu I; Horn S; Stieber D; Varughese JK; Spriet E; Dale HA; Skaftnesmo KO; Bjerkvig R; Thorsen F
    Int J Mol Sci; 2014 May; 15(5):8773-94. PubMed ID: 24840574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hydroquinone modulates the GM-CSF signaling pathway in TF-1 cells.
    Zheng JH; Pyatt DW; Gross SA; Le AT; Kerzic PJ; Irons RD
    Leukemia; 2004 Jul; 18(7):1296-304. PubMed ID: 15129224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways.
    Glasow A; Prodromou N; Xu K; von Lindern M; Zelent A
    Blood; 2005 Jan; 105(1):341-9. PubMed ID: 15339853
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
    Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PTEN sensitizes MDA-MB-468 cells to inhibition of MEK/Erk signaling for the blockade of cell proliferation.
    Jang K; Kim M; Seo HS; Shin I
    Oncol Rep; 2010 Sep; 24(3):787-93. PubMed ID: 20664988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
    Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP
    Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia.
    Fu L; Huang W; Jing Y; Jiang M; Zhao Y; Shi J; Huang S; Xue X; Zhang Q; Tang J; Dou L; Wang L; Nervi C; Li Y; Yu L
    FEBS J; 2014 Feb; 281(4):1123-31. PubMed ID: 24314118
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins.
    Yoshimi A; Goyama S; Watanabe-Okochi N; Yoshiki Y; Nannya Y; Nitta E; Arai S; Sato T; Shimabe M; Nakagawa M; Imai Y; Kitamura T; Kurokawa M
    Blood; 2011 Mar; 117(13):3617-28. PubMed ID: 21289308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional screen analysis reveals miR-3142 as central regulator in chemoresistance and proliferation through activation of the PTEN-AKT pathway in CML.
    Zhao L; Shan Y; Liu B; Li Y; Jia L
    Cell Death Dis; 2017 May; 8(5):e2830. PubMed ID: 28542127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pten loss in the bone marrow leads to G-CSF-mediated HSC mobilization.
    Tesio M; Oser GM; Baccelli I; Blanco-Bose W; Wu H; Göthert JR; Kogan SC; Trumpp A
    J Exp Med; 2013 Oct; 210(11):2337-49. PubMed ID: 24127490
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
    Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
    Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
    [TBL] [Abstract][Full Text] [Related]  

  • 53. E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression.
    Lau MT; Klausen C; Leung PC
    Oncogene; 2011 Jun; 30(24):2753-66. PubMed ID: 21297666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IGF1-induced AKT phosphorylation and cell proliferation are suppressed with the increase in PTEN during luteinization in human granulosa cells.
    Goto M; Iwase A; Harata T; Takigawa S; Suzuki K; Manabe S; Kikkawa F
    Reproduction; 2009 May; 137(5):835-42. PubMed ID: 19225041
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Granulocyte-macrophage colony-stimulating factor induces the transcriptional activation of egr-1 through a protein kinase A-independent signaling pathway.
    Wong A; Sakamoto KM
    J Biol Chem; 1995 Dec; 270(51):30271-3. PubMed ID: 8530445
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PTEN/MAPK pathways play a key role in platelet-activating factor-induced experimental pulmonary tumor metastasis.
    Kim HA; Kim KJ; Seo KH; Lee HK; Im SY
    FEBS Lett; 2012 Dec; 586(24):4296-302. PubMed ID: 23137704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contribution of both STAT and SRF/TCF to c-fos promoter activation by granulocyte-macrophage colony-stimulating factor.
    Rajotte D; Sadowski HB; Haman A; Gopalbhai K; Meloche S; Liu L; Krystal G; Hoang T
    Blood; 1996 Oct; 88(8):2906-16. PubMed ID: 8874187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PTEN sensitizes epidermal growth factor-mediated proliferation in endometrial carcinoma cells.
    Tang LL; Yokoyama Y; Wan X; Iwagaki S; Niwa K; Tamaya T
    Oncol Rep; 2006 Apr; 15(4):855-9. PubMed ID: 16525671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-term delay of Fas-stimulated apoptosis by GM-CSF as a result of temporary suppression of FADD recruitment in neutrophils: evidence implicating phosphatidylinositol 3-kinase and MEK1-ERK1/2 pathways downstream of classical protein kinase C.
    Kotone-Miyahara Y; Yamashita K; Lee KK; Yonehara S; Uchiyama T; Sasada M; Takahashi A
    J Leukoc Biol; 2004 Nov; 76(5):1047-56. PubMed ID: 15328334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogen-activated protein kinase pathway.
    Yu C; Wang S; Dent P; Grant S
    Mol Pharmacol; 2001 Jul; 60(1):143-54. PubMed ID: 11408609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.